L'Oréal

Barclays sees L’Oreal as the main beneficiary of the selective beauty market, where brand strength and innovation determine winners. Positive H1 results from Puig indicate continued demand in the premium and luxury segments, with fragrances and make-up remaining dynamic and dermocosmetics gaining market share. According to Barclays, L’Oreal scores particularly in dermocosmetics and records around 7% growth in the US and Europe, along with strong APAC growth. Recent developments: an exclusive 50‑year beauty license with Gucci (first products in 2028) and an analyst upgrade due to good inflation management. » More on de.investing.com

L'Oréal increased sales in the second quarter by around 8% to €11.6 billion; adjusted for currency effects and portfolio changes, growth was 6.3%. The share rose about 4% in Paris and is up roughly 9% year-to-date. In the first half, the group generated revenues of €23.8 billion, an operating profit of €5.06 billion (+6.8%) and a net profit of just over €3.5 billion (+5%); analysts described the figures overall as strong to solid under the leadership of Nicolas Hieronimus. » More on finanzen.net

L'Oreal increased group sales in the second quarter by 8.2 percent year-on-year to €11.62 billion. Adjusted for currency effects and portfolio changes, organic growth was 6.3 percent. Operating profit for the first half rose 6.8 percent to €5.06 billion, and the share price initially jumped about three percent. » More on finanzen.net